Middle East & Africa Microbiology CRO Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The microbiology Contract Research Organization (CRO) services market in the Middle East and Africa is projected to grow significantly, reaching approximately US$ 254.65 million by 2031, up from US$ 135.47 million in 2023. This growth represents a compound annual growth rate (CAGR) of 8.2% from 2023 to 2031.

Executive Summary and Market Analysis

The market is divided into key regions including Saudi Arabia, the UAE, South Africa, and the broader Middle East and Africa (MEA). Several factors are driving the growth of microbiology CRO services in this region, including the increasing prevalence of chronic diseases, a rise in clinical trials, heightened investments in healthcare development, growing healthcare expenditures, and various government initiatives and collaborations among market players.

Market Segmentation Analysis

The Middle East and Africa microbiology CRO services market can be segmented based on application, service type, microorganisms, and end users:

Application: The market is categorized into clinical, medical device, and other applications, with the clinical segment holding the largest market share in 2023.
Service Type: This segment includes assay development, custom viral stock production, microbial testing, and others, where microbial testing also dominated the market in 2023.
Microorganisms: The market is segmented into bacteria, fungi, viruses, and parasites, with bacteria being the leading segment in 2023.
End Users: The end-user categories include biotech and pharmaceutical companies, medical device companies, and others, with biotech and pharmaceutical companies holding the largest share in 2023.

Market Outlook

Clinical trials are essential for assessing the safety and efficacy of new medical products, drugs, diets, or devices. The National Library of Medicine (NLM) reported that around 52,000 new studies were registered in 2020, increasing to approximately 58,000 by 2023. As of January 2023, there were 38,837 active clinical trials in the US and 105,172 globally.

The complexity of clinical trials necessitates precise execution and monitoring, leading many research organizations to outsource these trials to CROs. CROs provide specialized expertise and high-quality facilities, becoming integral to the clinical trial process. According to Thermo Fisher Scientific, in 2022, CROs managed about 75% of clinical trials, enhancing efficiency and delivering high-quality data.

The growing awareness of microbiology testing's importance in ensuring product quality and safety-especially in vaccines, biologics, drugs, and medical devices-further propels the demand for microbiology CRO services. As pharmaceutical and biotech companies focus on their core competencies, they increasingly depend on CROs for clinical trial testing, driving market growth.

Country Insights

The microbiology CRO services market in the Middle East and Africa includes South Africa, Saudi Arabia, the UAE, and the Rest of MEA, with South Africa holding the largest market share in 2023. The growth in South Africa is supported by strategic initiatives from both private and government sectors. For instance, the Center for Infectious Diseases Research in Africa (CIDRI-Africa) promotes research to combat infections like HIV-1 and tuberculosis. Additionally, the Chan Soon-Shiong Family Foundation and the South Africa Medical Research Council have launched a capacity development program aimed at enhancing Africa's workforce in vaccine development and manufacturing.

Such initiatives are expected to positively influence the microbiology CRO services market in South Africa. Furthermore, local CROs like Novotech, OnQ Research, and LT Clinical Research (Pty) Ltd are providing microbiology services, contributing to market growth.

Company Profiles

Key players in the microbiology CRO services market include Microbiologics, Melbec Microbiology, Emery Pharma, TheraIndx Lifesciences Pvt. Ltd., AVERIN BIOTECH, Statens Serum Institut, ImQuest BioSciences, PACIFIC BIOLABS, Innovotech Inc., and BluTest Laboratories Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their clients.

Product Code: BMIRE00032144

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Middle East & Africa Microbiology CRO Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Practice of Outsourcing Clinical Studies with Massive Number of Trials
- 4.1.2 Surging Research and Development Investments
4.2 Market Restraints
- 4.2.1 Shortage of Skilled Professionals
4.3 Market Opportunities
- 4.3.1 Advancements in Microbiology Testing Technology
4.4 Future Trends
- 4.4.1 Rise in Partnerships and Collaborations with Service Providers
4.5 Impact of Drivers and Restraints:

5. Microbiology CRO Market - Middle East & Africa Analysis

5.1 Middle East & Africa Microbiology CRO Market Revenue (US$ Million), 2021-2031
5.2 Middle East & Africa Microbiology CRO Market Forecast Analysis

6. Middle East & Africa Microbiology CRO Market Analysis - by Application

6.1 Clinical
- 6.1.1 Overview
- 6.1.2 Clinical: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Medical Device
- 6.2.1 Overview
- 6.2.2 Medical Device: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Others
- 6.3.1 Overview
- 6.3.2 Others: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Middle East & Africa Microbiology CRO Market Analysis - by Service Type

7.1 Assay Development
- 7.1.1 Overview
- 7.1.2 Assay Development: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Custom Viral Stock Production
- 7.2.1 Overview
- 7.2.2 Custom Viral Stock Production: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Microbial Testing
- 7.3.1 Overview
- 7.3.2 Microbial Testing: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Microbiology CRO Market Analysis - by Microorganisms

8.1 Bacteria
- 8.1.1 Overview
- 8.1.2 Bacteria: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Fungi
- 8.2.1 Overview
- 8.2.2 Fungi: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Viruses
- 8.3.1 Overview
- 8.3.2 Viruses: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parasite
- 8.4.1 Overview
- 8.4.2 Parasite: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Microbiology CRO Market Analysis - by End User

9.1 Biotech and Pharmaceutical Companies
- 9.1.1 Overview
- 9.1.2 Biotech and Pharmaceutical Companies: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Medical Device Companies
- 9.2.1 Overview
- 9.2.2 Medical Device Companies: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Microbiology CRO Market - Country Analysis

10.1 Middle East and Africa
- 10.1.1 Middle East & Africa Microbiology CRO Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Middle East & Africa Microbiology CRO Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 South Africa: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 South Africa: Middle East & Africa Microbiology CRO Market Share - by Application
    - 10.1.1.2.2 South Africa: Middle East & Africa Microbiology CRO Market Share - by Clinical
    - 10.1.1.2.3 South Africa: Middle East & Africa Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.2.4 South Africa: Middle East & Africa Microbiology CRO Market Share - by Service Type
    - 10.1.1.2.5 South Africa: Middle East & Africa Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.2.6 South Africa: Middle East & Africa Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.2.7 South Africa: Middle East & Africa Microbiology CRO Market Share - by End User
  - 10.1.1.3 Saudi Arabia: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Application
    - 10.1.1.3.2 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Clinical
    - 10.1.1.3.3 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.3.4 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Service Type
    - 10.1.1.3.5 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.3.6 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.3.7 Saudi Arabia: Middle East & Africa Microbiology CRO Market Share - by End User
  - 10.1.1.4 United Arab Emirates: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Application
    - 10.1.1.4.2 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Clinical
    - 10.1.1.4.3 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.4.4 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Service Type
    - 10.1.1.4.5 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.4.6 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.4.7 United Arab Emirates: Middle East & Africa Microbiology CRO Market Share - by End User
  - 10.1.1.5 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Application
    - 10.1.1.5.2 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Clinical
    - 10.1.1.5.3 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.5.4 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Service Type
    - 10.1.1.5.5 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.5.6 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.5.7 Rest of Middle East and Africa: Middle East & Africa Microbiology CRO Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Microbiology CRO Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Microbiologics
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Melbec Microbiology
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emery Pharma
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 TheraIndx Lifesciences Pvt. Ltd.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 AVERIN BIOTECH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Statens Serum Institut
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ImQuest BioSciences
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PACIFIC BIOLABS
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Innovotech Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BluTest Laboratories Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 List of Abbreviations